Literature DB >> 8623907

Thymoma-associated myasthenia gravis. Transplantation of thymoma and extrathymomal thymic tissue into SCID mice.

S Spuler1, A Sarropoulos, A Marx, R Hohlfeld, H Wekerle.   

Abstract

To study the possible role of thymomas and of extrathymomal thymic tissue in the development and maintenance of myasthenia gravis, we transplanted fragments of either tissue into SCID mice and monitored the production of anti-acetylcholine receptor antibodies in the recipients. Furthermore, the transplants were characterized by immunohistochemistry. Unlike after transplantation of thymus with lymphofollicular hyperplasia that induced high titers of anti-acetylcholine receptor antibodies, thymoma transplants never produced autoantibodies. Mice transplanted with extrathymomal thymic tissue also failed to produce anti-acetylcholine receptor antibodies except one group that received transplants containing hyperplastic extrathymomal tissue. These findings may explain the refractoriness of thymomatous myasthenia to thymectomy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8623907      PMCID: PMC1861559     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  25 in total

1.  The pathology of the thymus gland in myasthenia gravis.

Authors:  B Castleman
Journal:  Ann N Y Acad Sci       Date:  1966-01-26       Impact factor: 5.691

2.  Thymic muscle cells bear acetylcholine receptors: possible relation to myasthenia gravis.

Authors:  I Kao; D B Drachman
Journal:  Science       Date:  1977-01-07       Impact factor: 47.728

3.  Intrathymic pathogenesis and dual genetic control of myasthenia gravis.

Authors:  H Wekerle; U P Ketelsen
Journal:  Lancet       Date:  1977-03-26       Impact factor: 79.321

4.  Observations of the natural history of myasthenia gravis and the effect of thymectomy.

Authors:  H J Oosterhuis
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

5.  Thymic abnormalities: antigen or antibody? Response to thymectomy in myasthenia gravis.

Authors:  A S Penn; A Jaretzki; M Wolff; H W Chang; V Tennyson
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

6.  Antibody to acetylcholine receptor in myasthenia gravis. Prevalence, clinical correlates, and diagnostic value.

Authors:  J M Lindstrom; M E Seybold; V A Lennon; S Whittingham; D D Duane
Journal:  Neurology       Date:  1976-11       Impact factor: 9.910

7.  A severe combined immunodeficiency mutation in the mouse.

Authors:  G C Bosma; R P Custer; M J Bosma
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

Review 8.  Myasthenia gravis and myasthenic syndromes.

Authors:  A G Engel
Journal:  Ann Neurol       Date:  1984-11       Impact factor: 10.422

9.  Myogenesis in thymic transplants in the severe combined immunodeficient mouse model of myasthenia gravis. Differentiation of thymic myoid cells into striated muscle cells.

Authors:  S Spuler; A Marx; T Kirchner; R Hohlfeld; H Wekerle
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

10.  Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.

Authors:  M Marino; H K Müller-Hermelink
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985
View more
  2 in total

1.  Preconditioned mesenchymal stem cells treat myasthenia gravis in a humanized preclinical model.

Authors:  Muriel Sudres; Marie Maurer; Marieke Robinet; Jacky Bismuth; Frédérique Truffault; Diane Girard; Nadine Dragin; Mohamed Attia; Elie Fadel; Nicola Santelmo; Camille Sicsic; Talma Brenner; Sonia Berrih-Aknin
Journal:  JCI Insight       Date:  2017-04-06

2.  Steroid therapy without primary dose escalation for postthymectomy crisis in 2 thymomatous myasthenia gravis patients.

Authors:  Masayoshi Inoue; Kentaro Kimura; Katsuko Hasegawa; Kiyohiro Fujiwara; Katsuhiro Nakagawa; Tsutomu Yasumitsu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2002-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.